Well, it's good to see that someone wants "in" in a big way.

AGM: Would love to hear from someone on the science side, the Eversana lead, and of course Don's current POV. Probably wishful thinking for anyone other than Don speaking, but I would love to see Eversana's RVX related leadership provide some insight.

Really need some direct unvarnished insight in financing, BoM2 & Covid timelines.

As many negatives as there are currently, and have been, let's just remember how close we were to BoM success despite a flawed study in several ways - BoM2 looks a lot better, as it should be while continuing to analyze and learn from previous shortcomins.

I still find it encouraging that Ori, Hepa, etc made RVX favorable strategic/financial decisions while in high leverage positions, betting on the future. They have a view from the board room.

Not holding my breath, but hopeful for some positive material news at the AGM.